You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View
Latest Type 2 Issues Articles
Popular Type 2 Issues Articles
Highly Recommended Type 2 Issues Articles
Send a link to this page to your friends and colleagues.
Not Just for Lipid-Lowering Anymore
According to a randomized 50-patient study in the Netherlands, after eight weeks of treatment with pravastatin (marketed in the United States as Pravachol), researchers observed significant reductions in three plasma coagulation and inflammation markers, as well as a 13 percent reduction in C-reactive protein, an indicator of inflammation.
The researchers speculate that the anti-thrombotic and anti-inflammatory effects of statin treatment could play a role in reducing the cardiovascular complications associated with type 2 diabetes.
-Diabetes Care, February 2004
Clinical adviser’s note: For more information on the class of lipid-regulating drugs called HMG-CoA reductase inhibitors (“statins” for short), please refer to our January 2004 Product Reference Guide issue, pp. 38-44.
Diabetes Health is the essential resource for people living with diabetes- both newly diagnosed and experienced as well as the professionals who care for them. We provide balanced expert news and information on living healthfully with diabetes. Each issue includes cutting-edge editorial coverage of new products, research, treatment options, and meaningful lifestyle issues.